BioPorto A/S
BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI); NGAL Test, a particle-enhanced turbidimetric immunoassay for the quantitative determination of neu… Read more
BioPorto A/S (THOXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.298x
Based on the latest financial reports, BioPorto A/S (THOXF) has a cash flow conversion efficiency ratio of -0.298x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.05 Million) by net assets ($57.22 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioPorto A/S - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how BioPorto A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioPorto A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioPorto A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Locaweb Serviços de Internet S.A.
SA:LWSA3
|
0.042x |
|
Innova Captab Limited
NSE:INNOVACAP
|
0.030x |
|
Zalaris ASA
OL:ZAL
|
0.250x |
|
CERENO SCIENTIFIC AB B
F:4A1
|
N/A |
|
Kis Wire
KO:002240
|
0.016x |
|
Camlin Fine Sciences Limited
NSE:CAMLINFINE
|
0.078x |
|
CCFNB Bancorp Inc
OTCQX:CCFN
|
0.041x |
|
Sariguna Primatirta PT
JK:CLEO
|
0.043x |
Annual Cash Flow Conversion Efficiency for BioPorto A/S (2005–2024)
The table below shows the annual cash flow conversion efficiency of BioPorto A/S from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $67.78 Million | $-83.58 Million | -1.233x | -33.78% |
| 2023-12-31 | $60.16 Million | $-55.46 Million | -0.922x | -23.33% |
| 2022-12-31 | $70.22 Million | $-52.48 Million | -0.747x | +46.80% |
| 2021-12-31 | $45.96 Million | $-64.58 Million | -1.405x | -298.07% |
| 2020-12-31 | $100.91 Million | $-35.62 Million | -0.353x | +85.15% |
| 2019-12-31 | $25.32 Million | $-60.16 Million | -2.376x | -251.29% |
| 2018-12-31 | $56.20 Million | $-38.01 Million | -0.676x | -29.70% |
| 2017-12-31 | $56.07 Million | $-29.24 Million | -0.521x | -17.48% |
| 2016-12-31 | $44.29 Million | $-19.66 Million | -0.444x | -19.14% |
| 2015-12-31 | $44.48 Million | $-16.57 Million | -0.373x | +33.77% |
| 2014-12-31 | $28.69 Million | $-16.14 Million | -0.563x | -40.68% |
| 2013-12-31 | $41.61 Million | $-16.64 Million | -0.400x | -103.01% |
| 2012-12-31 | $-1.15 Million | $-15.28 Million | 13.287x | +484.66% |
| 2011-12-31 | $3.94 Million | $-13.61 Million | -3.454x | +14.57% |
| 2010-12-31 | $3.31 Million | $-13.38 Million | -4.043x | -368.99% |
| 2009-12-31 | $15.41 Million | $-13.29 Million | -0.862x | +2.57% |
| 2008-12-31 | $15.50 Million | $-13.72 Million | -0.885x | -84.47% |
| 2007-12-31 | $29.45 Million | $-14.13 Million | -0.480x | -162.80% |
| 2006-12-31 | $-17.62 Million | $-13.46 Million | 0.764x | +16715.76% |
| 2005-12-31 | $-3.06 Million | $-13.88K | 0.005x | -- |